Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
Ho-Kee Yum, Hak-Ryul Kim, Yoon Soo Chang, Kyeong-Cheol Shin, Song Kim, Yeon-Mok Oh
Tuberc Respir Dis. 2017;80(1):52-59.   Published online 2016 Dec 30     DOI:
Citations to this article as recorded by Crossref logo
Dynamics of the splicing factor SRSF6 protein show metastable conformations with potentially druggable sites revealed by Markov state model
Ruiyu Bu, Wenying Yu, Maode Lai, Jinfeng Liu
Chemical Physics Letters.2024; 837: 141059.     CrossRef
Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan
Tomoko Taniguchi, Dong Wang, Hajime Yoshisue, Makoto Nagasaki, Takayoshi Sasajima
Internal Medicine.2021; 60(15): 2385.     CrossRef
Targeting Splicing Factor SRSF6 for Cancer Therapy
Wenting She, Jun Shao, Rong Jia
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer
Ledong Wan, Wenying Yu, Enhui Shen, Wenjie Sun, Yuan Liu, Jianlu Kong, Yihua Wu, Fengyan Han, Lei Zhang, Tianze Yu, Yuwei Zhou, Sunzhe Xie, Enping Xu, Honghe Zhang, Maode Lai
Gut.2019; 68(1): 118.     CrossRef
Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives
Chin Kook Rhee, Hajime Yoshisue, Rahul Lad
Advances in Therapy.2019; 36(3): 495.     CrossRef
Pharmacotherapy for chronic obstructive pulmonary disease
In Ae Kim, Yong Bum Park, Kwang Ha Yoo
Journal of the Korean Medical Association.2018; 61(9): 545.     CrossRef
The safety of indacaterol for the treatment of COPD
Evgenios I. Metaxas, Evangelos Balis
Expert Opinion on Drug Safety.2018; 17(6): 637.     CrossRef
Reactions Weekly.2017; 1645(1): 160.     CrossRef